.

Peter J. Skrdla

Ph.D.

Team Leader

GlaxoSmithKline plc., London · Department of Product Development

 

• 
  GlaxoSmithKline plc.

  Department of Product Development

  London, United Kingdom

  ABOUT

  Pete received his Ph.D. degree in chemistry from the University of Arizona in 1999. He joined Merck (MSD) in the same year and worked there until 2014, at which time he took a position at GSK. He has extensive experience in drug development, working on/leading cross-functional teams, mentoring scientists and managing multiple projects/staff. He is interested in analytical R&D, particle engineering, physical pharmacy, nanotechnology and formulation approaches for poorly bio-available drugs.

   

  Links

https://www.linkedin.com/in/peter-j-skrdla-5b44a92
https://www.researchgate.net/profile/Peter_Skrdla/info
http://www.americanpharmaceuticalreview.com/1429-AuthorProfile/2020-Peter-J-Skrdla/
http://www.pubfacts.com/author/Peter+J+Skrdla

Summary

Pete received his Ph.D. degree in chemistry from the University of Arizona in 1999. He joined Merck (MSD) in the same year and continued working there until 2014, progressing in his career from Senior Research Chemist to Principal Scientist. He has extensive experience in drug development, working on/leading cross-functional teams, mentoring other scientists and managing multiple projects/staff at the same time. He was directly involved in the commercialization of several Merck drugs, being responsible for both the technical and regulatory aspects of such.

In 2014, Pete joined GlaxoSmithKline (GSK) in the capacity of Team Leader, where he currently manages a group of scientists in the development of new pharmaceuticals (API and DP).
Pete's research interests include physical and chemical characterization, physical pharmacy, enabled formulations, nanotechnology, solid-state phase transformations, modeling, chromatography and thermal analysis (https://www.researchgate.net/profile/Peter_Skrdla/).

Education

University of Arizona

Ph.D., Chemistry

1995 – 1999

Experience

Team Leader

GSK

May 2014 – Present (1 year 8 months)Upper Providence, PA

Coordinates the activities of a group of scientists in support of the development of new medicines. Participates on cross-functional teams with the same mission.

Principal Scientist, ADC, MMD

Merck

April 2013 – March 2014 (1 year)Rahway, NJ

Technical Team Lead (TTL)

Principal Scientist, Preformulation, MRL

Merck

October 2012 – May 2013 (8 months)Summit, NJ

Preformulation scientist working on preparing and characterizing prototype formulations, enabled formulations (rotational opportunity)

Senior Investigator, MMD

Merck & Co., Inc.

January 2008 – August 2012 (4 years 8 months)Rahway, NJ

Analytical team leader, ADC

Principal Analytical Chemist, MMD

Merck

January 2007 – December 2007 (1 year)Rahway, NJ

Group leader, Analytical Development & Commercialization (ADC)

Research Fellow, MRL

Merck

August 2002 – December 2006 (4 years 5 months)Rahway, NJ

Group leader, Analytical Research (AR)

Senior Research Chemist, MRL

Merck & Co., Inc.

July 1999 – August 2002 (3 years 2 months)Rahway, NJ

Ph.D. scientist and project leader, Analytical Research (AR)

RESEARCH EXPERIENCE

• Jul 1999–present

  Principal Investigator

  Merck · Analytical Chemistry and Development
  United States · Whitehouse Station
• Sep 1995–Jul 1999

  Research/Teaching Assistant

  The University of Arizona · Department of Chemistry and Biochemistry (College of Science) · Saavedra and Armstrong
  United States · Tucson

AWARDS & ACHIEVEMENTS

• Jan 2013
  Award: Merck Discovery Pharmaceutical Sciences Team Award
• Aug 2012
  Award: Merck Technology Roadmap
• May 2010
  Award: Merck Brinavess Launch Team
• May 2007
  Award: Merck Emend-IV Launch Team
• May 1997
  Scholarship: Graduate Mid-Career Fellowship

 

///////////

CPhI India, Dec2015, MUMBAI, INDIA.

 

With Dr Charlotte Wiles, CEO, CHEMTRIX BV , Cambridge, UK at CPhI India, Dec2015, MUMBAI, INDIA......At Pi-inc (Process Intensification Experts LLP) stall, hall 5 H47,


Meet her at.............. http://selectbiosciences.com/conferences/index.aspx?conf=FCINDIA16&se=india

Flow Chemistry India 2016

Date: Thursday, 21 January 2016 - Friday, 22 January 2016
Location: Mumbai

 


At Pi-inc (Process Intensification Experts LLP) stall, hall 5 H47, seen is Asif rangwala of ATR-ASAHI GLASS


 

At Pi-inc (Process Intensification Experts LLP) stall, hall 5 H47, seen is Mr Vijay Kirpalani with Charlotte wiles —

Harold E Varmus

Harold Eliot Varmus is an American Nobel Prize-winning scientist and the 14th Director of the National Cancer Institute, a post to which he was appointed by President Barack Obama. He was a co-recipient of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviraloncogenes. He also serves as one of three co-Chairs of thePresident's Council of Advisors on Science and Technology.

Continue Reading

Manish Gore, 

With Prof. Harold Varmus! 

smile emoticon — at Hebrew University of Jerusalem.

JERUSALEM ISRAEL

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

Join me on Facebook FACEBOOK

Join me on twitter     

Join me on google plus Googleplus

 amcrasto@gmail.com

/////////

Dr. Sandeep N. Raikar

.

 Dr. Sandeep N. Raikar

Dr. Sandeep N. Raikar did his BSc and MSc from Sri Satya Sai Institute of Higher Learning-India. He then moved to University of Kansas where he worked with Prof. Helena C. Malinakova and obtained his Ph.D. degree in 2013. Currently he is a postdoctoral associate in Prof. Huw M. L. Davies laboratory at Emory University.

////////////






 DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

Join me on Facebook FACEBOOK

Join me on twitter     

Join me on google plus Googleplus

 amcrasto@gmail.com

Jin-Quan Yu

.
 Jin-Quan Yu


Jin-Quan Yu received his BSc in Chemistry from East China Normal University and his MSc from the Guangzhou Institute of Chemistry. In 2000, he obtained his PhD at the University of Cambridge with Prof. J. B. Spencer. Following time as a junior research fellow at Cambridge, he joined the laboratory of Prof. E. J. Corey at Harvard University as a postdoctoral fellow. He then began his independent career at Cambridge (2003-2004), before moving to Brandeis University (2004-2007), and finally to The Scripps Research Institute, where he is currently Frank and Bertha Hupp Professor of Chemistry. His group studies transition metal-catalyzed C-H activation.

 Department of Chemistry, The Scripps Research Institute (TSRI), 10550 N. Torrey Pines Road, La Jolla, CA 92037 (USA). E-mail: yu200@scripps.edu.








/////////////

Keary Mark Engle

.

Keary Mark Engle


  Keary Mark Engle graduated Phi Beta Kappa and summa cum laude from the University of Michigan, where he worked with Prof. Adam Matzger studying self-assembled monolayers. A Fulbright Scholar, he spent the 2007-2008 academic year studying under the tutelage of Prof. Manfred Reetz at the Max-Planck-Institut für Kohlenforschung (Germany). He completed his graduate work jointly at The Scripps Research Institute and the University of Oxford, under the supervision of Prof. Jin-Quan Yu and Prof. Véronique Gouverneur, respectively, earning a Ph.D. in Chemistry and a DPhil in Biochemistry. During graduate school, his honors included NSF and NDSEG Predoctoral Fellowships. Presently, Keary is an NIH Postdoctoral Fellow with Prof. Robert H. Grubbs at Caltech.









//////////

Dong-Hui Wang

.

 Dong-Hui Wang


 Dong-Hui Wang completed his BSc at Lanzhou University in 2000 then carried out research at the Shanghai Institute of Organic Chemistry under Prof. Zhaoguo Zhang. In 2004, he began graduate studies under Prof. Jin-Quan Yu. He earned his MSc from Brandeis University before relocating to The Scripps Research Institute, where he completed his Ph.D. in 2010. His thesis research was recognized with the Chinese Government Award for Outstanding Self-Financed Students Abroad. Dong-Hui worked as a postdoctoral research fellow in the laboratory of Prof. Stephen Buchwald at MIT (2010-2012), and as a medicinal chemist at Abide Therapeutics (2012-2014). Presently, he is an Assistant Professor at the Shanghai Institute of Organic Chemistry (China).










////////////